MedSurg and Neurotechnology — Additions and adjustments
Stryker MedSurg and Neurotechnology — Additions and adjustments decreased by 109.0% to -$74M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 109.0%, from $818.75M to -$74M. Over 4 years (FY 2021 to FY 2025), MedSurg and Neurotechnology — Additions and adjustments shows an upward trend with a 95.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase suggests higher non-recurring costs or restructuring activities, while a decrease indicates a more stable operational environment with fewer extraordinary charges.
Detailed definition
This metric represents non-recurring or non-operational financial adjustments specific to the MedSurg and Neurotechnolog...
Peer comparison
Similar to 'special items' or 'restructuring and other charges' reported by peers in the medical device industry.
syk_segment_medsurg_and_neurotechnology_additions_and_adjustmentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $55.75M | $55.75M | $55.75M | $580M | $580M | $580M | $580M | $75.25M | $75.25M | $75.25M | $75.25M | $213M | $213M | $213M | $213M | $818.75M | $818.75M | $818.75M | $818.75M | -$74M |
| QoQ Change | — | +0.0% | +0.0% | +940.4% | +0.0% | +0.0% | +0.0% | -87.0% | +0.0% | +0.0% | +0.0% | +183.1% | +0.0% | +0.0% | +0.0% | +284.4% | +0.0% | +0.0% | +0.0% | -109.0% |
| YoY Change | — | — | — | — | +940.4% | +940.4% | +940.4% | -87.0% | -87.0% | -87.0% | -87.0% | +183.1% | +183.1% | +183.1% | +183.1% | +284.4% | +284.4% | +284.4% | +284.4% | -109.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's medsurg and neurotechnology — additions and adjustments?
- Stryker (SYK) reported medsurg and neurotechnology — additions and adjustments of -$74M in Q1 2026.
- How has Stryker's medsurg and neurotechnology — additions and adjustments changed year-over-year?
- Stryker's medsurg and neurotechnology — additions and adjustments decreased by 109.0% year-over-year, from $818.75M to -$74M.
- What is the long-term trend for Stryker's medsurg and neurotechnology — additions and adjustments?
- Over 4 years (2021 to 2025), Stryker's medsurg and neurotechnology — additions and adjustments has grown at a 95.8% compound annual growth rate (CAGR), from $223M to $3.28B.
- What does medsurg and neurotechnology — additions and adjustments mean?
- One-time or non-recurring financial charges or adjustments impacting the segment's reported earnings.